about
Pruritus Reduction with Systemic Anti-lymphoma Treatments in Patients with Cutaneous T Cell Lymphoma: A Narrative ReviewTargeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategyChronic pruritus: a paraneoplastic signAprepitant for refractory cutaneous T-cell lymphoma-associated pruritus: 4 cases and a review of the literatureAnatomy and neurophysiology of pruritus.Psychoneuroimmunology of psychological stress and atopic dermatitis: pathophysiologic and therapeutic updates.TRPA1 controls inflammation and pruritogen responses in allergic contact dermatitis.Therapy of pruritus.Role of spinal neurotransmitter receptors in itch: new insights into therapies and drug development.Targeted treatment of pruritus: a look into the futurePruritus in cutaneous T-cell lymphoma: a review.Medical treatment of pruritus.Investigational drugs for pruritus.Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?Advances in therapeutic strategies for the treatment of pruritus.Chronic Pruritus in the Absence of Skin Disease: Pathophysiology, Diagnosis and Treatment.Substance P activates Mas-related G protein-coupled receptors to induce itch.Are itch and scratching the nausea and vomiting of skin?Neurokinin-1 receptor antagonist orvepitant is an effective inhibitor of itch-associated response in a Mongolian gerbil model of scratching behaviour.Treatment of pruritus in early-stage hypopigmented mycosis fungoides with aprepitant.Topical non-peptide antagonists of sensory neurotransmitters substance P and CGRP do not modify patch test and prick test reactions: a vehicle-controlled, double-blind pilot study.Aprepitant for the Treatment of Chronic Refractory Pruritus.Oral aprepitant in the therapy of refractory pruritus in erythrodermic cutaneous T-cell lymphoma.Skin neurogenic inflammation.Pruritus: From the Bench to the Bedside.
P2860
Q28075343-0DFA6564-CFE0-41F5-A266-F38C25FD3C28Q28751738-84C279C7-8BEC-4768-88D6-70D7572F5C5AQ35148381-278E8F64-4A84-4FEC-B702-4FB03AB1CD53Q36311246-57022E2C-C3FD-4C43-951A-F165A25F15E5Q36960447-9B0D1377-37F1-4C8B-82AD-9914C7ECE758Q36991454-5CD2CED0-3DB2-4DB8-B4A1-374EB1780B7AQ37118783-AA527AE0-436D-4E6A-B8EA-196282DABE63Q37738911-2E4A7703-396E-40D7-8F2F-1A6E764C4722Q37800506-22C48932-559E-4F1B-8993-D7BED03013CEQ37827172-3C1D7AAA-90F0-49D3-9E7D-D56C1C52D27EQ37979593-2A4F0EA6-3F39-4CAB-8C25-F1BBD25DA02BQ38032599-A9F46D95-5E29-4B61-B96A-7F07245A0AA0Q38118383-502C45F6-BC51-4ECD-B7A7-F1B0BF0A07D9Q38452688-CF6E950F-A989-4322-932B-8C767075D8E4Q38656850-BB1CE713-4200-4ED5-BDB3-D8B9C4C0FA6EQ38842371-18CE9AE2-B014-4F63-8A3F-CBD6C8A36638Q41285293-47F49839-FB6D-40F2-A406-FBA017552309Q42242954-F7904928-BA9D-4C3D-BAD8-BADB25E1B568Q43908243-2CE74785-97B1-4C83-B365-B48166F015D1Q44849246-83FA93A0-8247-4D50-B74A-96E953440499Q46850063-65105590-A9F4-493A-8686-EA9E41DCF504Q47141491-916FDC96-0DCA-4FD6-AA69-0C3EB399EA99Q48774158-AAB479E5-366A-4D89-96EA-59AD6FAE6532Q54224167-26ADEC40-BFA4-4EC1-AA12-FF317E7809B3Q55311868-A977BB1C-4A7B-456A-9D14-25EE9B2CA07A
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Aprepitant as an antipruritic agent?
@en
Aprepitant as an antipruritic agent?
@nl
type
label
Aprepitant as an antipruritic agent?
@en
Aprepitant as an antipruritic agent?
@nl
prefLabel
Aprepitant as an antipruritic agent?
@en
Aprepitant as an antipruritic agent?
@nl
P356
P1476
Aprepitant as an antipruritic agent?
@en
P2093
Arnaud Duval
Louis Dubertret
P304
P356
10.1056/NEJMC0906670
P407
P577
2009-10-01T00:00:00Z